FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
35,611,859
Share change
+8,217,024
Total reported value
$891,731,278
Put/Call ratio
111%
Price per share
$25.04
Number of holders
136
Value change
+$207,638,858
Number of buys
97
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q4 2017

As of 31 Dec 2017, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,611,859 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, Bank of New York Mellon Corp, MILLER VALUE PARTNERS, LLC, BlackRock Inc., STATE STREET CORP, WELLS FARGO & COMPANY/MN, Vanguard Group Inc, PICTET ASSET MANAGEMENT LTD, and Rubric Capital Management LP. This page lists 136 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.